Obesity leads to body processes that can promote cancer growth
the ONA take:
People who are obese are at higher risk for developing cancer, because extra body fat interferes with processes such as hormone cycles and glucose and fat metabolism. Obesity, defined as a body mass index (BMI) of more than 30, is increasing in industrialized countries.
New international studies show that 5.4% of all cancers in women and 1.9% of cancers in men are associated with high BMI, in particular esophageal, bowel, kidney, and pancreatic cancers, and in women, gallbladder, ovarian, uterine cancers, and postmenopausal breast cancer.
Research has shown that abdominal fat significantly increases the risk for several reasons. Hormonally active fatty tissue produces adipose tissue hormones and the changes the balance of sex hormones. Insulin resistance is increased, resulting in overproduction of insulin leading to diabetes.
In addition, chronic inflammatory processes can occur in the region of abdominal fat. All these factors can contribute to increased cell division and can support tumor growth.
On a positive note, the researchers point out that these risks can be minimized by weight loss or maintaining a healthy weight from the outset.
Diet and exercise are also helpful measures. These behaviors can help people avoid many types of cancers.
People who are obese are at higher risk for developing cancer, because extra body fat interferes with processes.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- PPIs Negatively Impact Outcomes of Patients Treated With Capecitabine
- How Physical Changes From Breast Cancer Affect Self-Image: Considerations for Clinicians
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Atypical Teratoid/rhabdoid Tumors: Challenges and Search for Solutions
- New Research Identifies Potential Bladder Cancer Chemotherapy Side Effect
- Pseudohyperkalemia: False Potassium Levels Occur in a Patient With Lymphoma
- Atezolizumab Granted FDA Approval for Specific Cases of NSCLC
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|